← Eichor
Condition: Respiratory Synctial Virus Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Respiratory Synctial Virus

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

COMMUNITY - the COVID-19 Immunity Study
Phase N/A · 2 location(s) · Danderyd Hospital · NCT06784739A Study to Confirm the Effectiveness and Safety of AK0529 in Treating RSV Infections in Hospitalized Infants
Phase 3 · 18 location(s) · Shanghai Ark Biopharmaceutical Co., Ltd. · NCT06775405Infant RSV Immunity Study
Phase N/A · 1 location(s) · University of British Columbia · NCT07653347Evaluation of the Effect of Nirsevimab on Hospitalizations Due to RSV Infection in Infants Under One Year of Age.
Phase N/A · 8 location(s) · Meyer Children's Hospital IRCCS · NCT06856967Respiratory Syncytial Virus Infection in Exacerbations of Chronic Obstructive Pulmonary Diasease: the RECODE Study
Phase N/A · 1 location(s) · Fundacio Privada Mon Clinic Barcelona · NCT06735612
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.